NCT06597513 2024-10-15Auto-HSCT-Supported Dose-Dense Chemotherapy with Adebrelimab As First-Line Treatment for ES-SCLCGuangzhou Institute of Respiratory DiseasePhase 1/2 Not yet recruiting10 enrolled